Epidemiology and natural history of HCV infection. (Q38118578)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23817321%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

Epidemiology and natural history of HCV infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23817321%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23817321%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

3

Gregory J Dore

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23817321%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

2

Jason Grebely

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23817321%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

language of work or name

English

0 references

publication date

2 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23817321%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Gastroenterology & Hepatology

4 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23817321%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23817321%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23817321%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

553-562

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23817321%20AND%20SRC:MED&resulttype=core&format=json

What is killing people with hepatitis C virus infection?

4 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

The changing therapeutic landscape for hepatitis C.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Curing hepatitis C with pills: a step toward global control

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

The global burden of hepatitis C

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Global burden of disease (GBD) for hepatitis C.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Evolving epidemiology of hepatitis C virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Hepatitis C virus infection in cameroon: A cohort-effect.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

HCV burden of infection in Egypt: results from a nationwide survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Surveillance and epidemiology of hepatitis B and C in Europe - a review.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Hepatitis C virus seroprevalence in the Netherlands

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Hepatitis C in the general adult population of Oslo: prevalence and clinical spectrum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995-2000.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Epidemiology of hepatitis C virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Hepatitis C virus infection in USA: an estimate of true prevalence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Epidemiology of hepatitis C in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Incidence and Transmission Patterns of Acute Hepatitis C in the United States, 1982-2006

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Modelling the hepatitis C virus epidemic in Australia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Molecular evolutionary analyses implicate injection treatment for schistosomiasis in the initial hepatitis C epidemics in Japan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Prevalence of hepatitis C in Romania: different from European rates?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Prevalence of hepatitis C virus and distribution of its genotypes in Northern Eurasia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

An incident case-control study of modes of hepatitis C virus transmission in France

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Cohort Profile: the Swiss Hepatitis C Cohort Study (SCCS).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Evaluation of the French national plan to promote screening and early management of viral hepatitis C, between 1997 and 2003: a comparative cross-sectional study in Poitou-Charentes region

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

The impact of the prevention programme of hepatitis C over more than a decade: the French experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Hepatitis C virus infection in Eastern Europe

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

The changing epidemiology of hepatitis C virus infection in Europe

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

HCV iatrogenic and intrafamilial transmission in Greater Cairo, Egypt.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Dissection of familial correlations in hepatitis C virus (HCV) seroprevalence suggests intrafamilial viral transmission and genetic predisposition to infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Intrafamilial transmission of hepatitis C in Egypt

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Hepatitis C virus in Pakistan: A systematic review of prevalence, genotypes and risk factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Seroprevalence of hepatitis C virus: the first population-based study from Iran

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

General Epidemiological Parameters of Viral Hepatitis A, B, C, and E in Six Regions of China: A Cross-Sectional Study in 2007

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Hepatitis C seroprevalence and associated risk factors, Anyang, China

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Injection Drug Use Is a Risk Factor for HCV Infection in Urban Egypt

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Risk factors for hepatitis C virus infection among blood donors in northern Thailand

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Molecular epidemiology of hepatitis C in Australia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Changing HCV genotypes distribution in Poland--relation to source and time of infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Genetic characterization of hepatitis C virus strains in Estonia: fluctuations in the predominating subtype with time

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

HCV genotype 4 in Belgium: three distinct patterns among patients from European and African origin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

High prevalence of hepatitis C virus subtypes 4c and 4d in Malaga (Spain): phylogenetic and epidemiological analyses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Hepatitis C genotype 4: What we know and what we don't yet know.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

The unexpected discovery of a focus of hepatitis C virus genotype 5 in a Syrian province

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Biological and clinicopathological features associated with hepatitis C virus type 5 infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Molecular epidemiology of hepatitis C genotype 6a from patients with chronic hepatitis C from Hong Kong

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Epidemiology of hepatitis C: geographic differences and temporal trends

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Cancer mortality trend analysis in Italy, 1970-2007.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Liver cancer and hepatitis B and C in New South Wales, 1990-2002: a linkage study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Modelling the past, current and future HCV burden in France: detailed analysis and perspectives

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Simulation of hepatitis C based on a mandatory reporting system.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Prospective evaluation of community-acquired acute-phase hepatitis C virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Testing Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence Rates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Dynamics of viremia in early hepatitis C virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Case definitions for acute hepatitis C virus infection: a systematic review.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Improving the Diagnosis of Acute Hepatitis C Virus Infection with Expanded Viral Load Criteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Viral and host factors in early hepatitis C virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Induction and evasion of innate antiviral responses by hepatitis C virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Does the clinical outcome of hepatitis C infection vary with the infecting hepatitis C virus type?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Hepatitis C infection in African Americans: its natural history and histological progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Fibrogenic impact of high serum glucose in chronic hepatitis C.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Impact of smoking on histological liver lesions in chronic hepatitis C.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Cigarette smoking and hepatic lesions in patients with chronic hepatitis C.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Estimating progression to cirrhosis in chronic hepatitis C virus infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Time to rethink antiviral treatment for hepatitis C in patients with coexisting mental health/substance abuse issues.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Outcomes of treatment for hepatitis C virus infection by primary care providers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Education by a nurse increases response of patients with chronic hepatitis C to therapy with peginterferon-α2a and ribavirin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug users

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

The acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug users

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Integrating HCV services for drug users: a model to improve engagement and outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Rate and predictors of treatment prescription for hepatitis C.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Market uptake of new antiviral drugs for the treatment of hepatitis C.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

Public health impact of antiviral therapy for hepatitis C in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.107

High prevalence of Hepatitis C virus genotype 6 in Vietnam

31 March 2020

1 reference

12 December 2020

The global health burden of hepatitis C virus infection

1 reference

12 December 2020

Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey

1 reference

12 December 2020

New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a

1 reference

12 December 2020

Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy

1 reference

12 December 2020

Hepatitis C genotypes and subtypes in Saudi Arabia

1 reference

12 December 2020

The epidemiology of hepatitis C virus infection in Sweden

1 reference

12 December 2020

Natural history of chronic hepatitis C

1 reference

12 December 2020

Progress toward prevention and control of hepatitis C virus infection--Egypt, 2001-2012.

1 reference

12 December 2020

Changing pattern of clinical epidemiology on hepatitis C virus infection in southwest china

1 reference

12 December 2020

Hepatitis C--global prevalence (update)

1 reference

12 December 2020